• A Prognostic Model to Facilitate Palliative Care Referral in Oncology Outpatients

• Kim Yu-Jung

• Hiratsuka Yusuke, Suh Sang-Yeon, Kang Beo-Deul, Lee Si-Won, Ahn Hong-Yup, Suh Koung-Jin, K...

• ´ëÇѾÏÇÐȸÁö   2022  Volume.54  No.2 621 ~ 629

• Predictive Factors of Event-Free Survival at 24 Months in Patients with Peripheral T-Cell Lymphoma: ...

• Kim Yu-Ri

• Kim Soo-Jeong, Lee Hye-Sun, Jeon So-Young, Cho Hyun-Soo, Chung Hae-Rim, Jang Ji-Eun, Cheon...

• ´ëÇѾÏÇÐȸÁö   2022  Volume.54  No.2 613 ~ 620

• Plasma Circulating Tumor DNA in Patients with Primary Central Nervous System Lymphoma

• Yoon Sang-Eun

• Kim Yeon-Jeong, Shim Joon-Ho, Park Dong-Hyun, Cho Jun-Hun, Ko Young-Hyeh, Park Woong-Yang, ...

• ´ëÇѾÏÇÐȸÁö   2022  Volume.54  No.2 597 ~ 612

• Incidence Patterns and Outcomes of Ewing Sarcoma in South Korea (1999?2017): A Retrospective Analysi...

• Lee Jun-Ah

• Lim Ji-Won, Park Da-Yeon, Jin Hye-Young, Park Mee-Rim, Park Hyeon-Jin, Park Jong-Woong, Ki...

• ´ëÇѾÏÇÐȸÁö   2022  Volume.54  No.2 590 ~ 596

• Clinicopathologic Characteristics and Clinical Outcome of Localized Liposarcoma: A Single-Center Exp...

• Chae Hee-Jung

• Kim Jeong-Eun, Kim Wan-Lim, Lee Jong-Seok, Song Si-Yeol, Lee Min-Hee, Chung Hye-Won, Cho K...

• ´ëÇѾÏÇÐȸÁö   2022  Volume.54  No.2 579 ~ 589

• Epidemiology of Acute Leukemia among Children with Down Syndrome in Korea

• Choi Young-Bae

• Yoo Keon-Hee

• ´ëÇѾÏÇÐȸÁö   2022  Volume.54  No.2 572 ~ 578

• Vincristine, Irinotecan, and Temozolomide as a Salvage Regimen for Relapsed or Refractory Sarcoma in...

• Ju Hee-Young

• Park Mee-Rim, Lee Jun-Ah, Park Hyeon-Jin, Park Seog-Yun, Kim June-Hyuk, Kang Hyun-Guy, Yan...

• ´ëÇѾÏÇÐȸÁö   2022  Volume.54  No.2 563 ~ 571

• Effectiveness of Concomitant Chemoradiotherapy with Gemcitabine in Locally Advanced Cervical Cancer ...

• Brau-Figueroa Hasan

• Arango-Bravo Eder, Castro-Eguiluz Denisse, Galicia-Carmona Tatiana, Lugo-Alferez Leopoldo Abraham, C...

• ´ëÇѾÏÇÐȸÁö   2022  Volume.54  No.2 554 ~ 562

• Inhibition of WEE1 Potentiates Sensitivity to PARP Inhibitor in Biliary Tract Cancer

• Seo Hye-Rim

• Nam Ah-Rong, Bang Ju-Hee, Oh Kyoung-Seok, Kim Jae-Min, Yoon Jee-Sun, Kim Tae-Yong, Oh Do-Y...

• ´ëÇѾÏÇÐȸÁö   2022  Volume.54  No.2 541 ~ 553

• A Hypoxia-Induced SCFFBXL1 E3 Ligase Ubiquitinates and Degrades the MEN1 Tumor Suppressor to Promote...

• Zeng Jun

• Xiao Xiao-Qing, Zhou Zhi-Yong

• ´ëÇѾÏÇÐȸÁö   2022  Volume.54  No.2 525 ~ 540

• Machine Learning Model for Predicting Postoperative Survival of Patients with Colorectal Cancer

• Osman Mohamed Hosny

• Mohamed Reham Hosny, Sarhan Hossam Mohamed, Park Eun-Jung, Baik Seung-Hyuk, Lee Kang-Young, Kan...

• ´ëÇѾÏÇÐȸÁö   2022  Volume.54  No.2 517 ~ 524

• Real-World Efficacy Data and Predictive Clinical Parameters for Treatment Outcomes in Advanced Esoph...

• Kim Jwa-Hoon

• Ahn Bo-Kyung, Hong Seung-Mo, Jung Hwoon-Yong, Kim Do-Hoon, Choi Kee-Don, Ahn Ji-Yong, Lee ...

• ´ëÇѾÏÇÐȸÁö   2022  Volume.54  No.2 505 ~ 516

• Postmastectomy Radiation Therapy for Node-Negative Breast Cancer of 5 cm or Larger Tumors: A Multice...

• Kim Kyu-Bo

• Jung Jin-Hong, Kim Hae-Young, Jung Won-Guen, Shin Kyung-Hwan, Chang Ji-Hyun, Kim Su-Ssan, ...

• ´ëÇѾÏÇÐȸÁö   2022  Volume.54  No.2 497 ~ 504

• A Real-World Efficacy of Nab-Paclitaxel Monotherapy in Metastatic Breast Cancer

• Kim Jung-Sun

• Suh Koung-Jin, Lee Dae-Won, Woo Go-Un, Kim Mi-So, Kim Se-Hyun, Ryu Han-Suk, Lee Kyung-Hun,...

• ´ëÇѾÏÇÐȸÁö   2022  Volume.54  No.2 488 ~ 496

• Effect of Postoperative Radiotherapy after Primary Tumor Resection in De Novo Stage IV Breast Cancer...

• Kim Yeon-Joo

• Kim Yeon-Joo, Kim Yong-Bae, Lee Ik-Jae, Kwon Jeanny, Kim Kyu-Bo, Cha Ji-Hye, Kim Myung-Soo...

• ´ëÇѾÏÇÐȸÁö   2022  Volume.54  No.2 478 ~ 487

• Comparison of the Effectiveness and Clinical Outcome of Everolimus Followed by CDK4/6 Inhibitors wit...

• Jeong Hye-Hyun

• Jeong Jae-Ho, Kim Jeong-Eun, Ahn Jin-Hee, Jung Kyung-Hae, Kim Sung-Bae

• ´ëÇѾÏÇÐȸÁö   2022  Volume.54  No.2 469 ~ 477

• Histone Deacetylase as a Valuable Predictive Biomarker and Therapeutic Target in Immunotherapy for N...

• Shin Hyun-Seock

• Choi Ju-Whan, Lee Jin-Hwan, Lee Sung-Yong

• ´ëÇѾÏÇÐȸÁö   2022  Volume.54  No.2 458 ~ 468

• miR-4487 Enhances Gefitinib-Mediated Ubiquitination and Autophagic Degradation of EGFR in Non?Small ...

• Kim Mi-Seong

• Kim So-Hui, Yang Sei-Hoon, Kim Min-Seuk

• ´ëÇѾÏÇÐȸÁö   2022  Volume.54  No.2 445 ~ 457

• The Clinical Outcomes of Different First-Line EGFR-TKIs Plus Bevacizumab in Advanced EGFR-Mutant Lun...

• Huang Yen-Hsiang

• Hsu Kuo-Hsuan, Chin Chun-Shih, Tseng Jeng-Sen, Yang Tsung-Ying, Chen Kun-Chieh, Su Kang-Yi,&nbs...

• ´ëÇѾÏÇÐȸÁö   2022  Volume.54  No.2 434 ~ 444

• Comparison of the Predictive Power of a Combination versus Individual Biomarker Testing in Non?Small...

• Kim Hyo-Jin

• Kwon Hyun-Jung, Kim Eun-Sun, Kwon Soo-Hyeon, Suh Kyoung-Jin, Kim Se-Hyun, Kim Yu-Jung, Lee...

• ´ëÇѾÏÇÐȸÁö   2022  Volume.54  No.2 424 ~ 433